SAMUEL ANG, Global Access Lead, Takeda

Sam Ang is the global patient value and access lead for oncology in Takeda. He has 17 years of industry global and region market access experience in five biopharma companies Pfizer, Abbott, Lilly, Amgen and Takeda. Within market access, Sam’s expertise includes payer value strategy, pricing & reimbursement, health policy, patient access and key account strategy. He has led market access strategy in each stage of product lifecycle from pipeline development, through launch, indication expansion to loss of exclusivity lifecycle management.

Previously, Sam was a legal counsel for the Singapore government and a strategy management consultant with Bain & Company. Sam has a law degree from Singapore, MBA from Imperial College London, and MPA from Harvard University.